A research agenda focusing on breakthrough infections, reinfections, severity, and sequelae is needed to inform clinical practice when COVID-19 emphasis shifts from eradication to living with the disease.
Paul Monach, MD, PhD
Advertisement
Paul Monach, MD, PhD is chief of rheumatology at the VA Boston Healthcare System and a researcher focused on clinical trials. Monach is affiliated with Harvard Medical School.
Articles by Paul Monach, MD, PhD
In the age of COVID-19, providers caring for patients with emerging diseases do not rely entirely on clinical guidelines, but also consult online resources that are updated more frequently. This needed integration helps providers adapt to the best-available evidence into bedside care when guidance is lacking.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
One Third of Chronic Hepatitis B Patients Are Lost to Follow-Up
2
Higher Acceptability of 1 Injectable in First Head-to-Head Comparison of Long-Acting PrEP
3
Antibiotic Shows Promise in Treating Gram-Positive Pneumonia, Including in High-Risk Patients
4
DOOR Analysis Shows Antibiotic Matches Standard Therapy in Effectiveness
5
